ALKBH5 and glioblastoma: To investigate the potential therapeutic value of the small molecule TRAD01 in GBM, we measured its inhibitory concentration (IC50) in DCD7# cells (Figure S6E) and verified its ability to effectively block the binding of ALKBH5 and TDP‐43 via anti‐ALKBH5 and anti‐TDP‐43 Co‐immunoprecipitation (Co‐IP) in TRAD01‐treated DCD_7# cells (Figure 7C).